Smith & Nephew plc vs ProShares Ultra Gold ETF — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while ProShares Ultra Gold ETF trades at $45.27. The key difference: Smith & Nephew plc pays a 2.57% dividend while ProShares Ultra Gold ETF pays none. Which is the better fit depends on your goals.
| SNN | UGL | |
|---|---|---|
Market Cap | $12.64B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $38.70 | $85.62 |
52-Week Low | $28.73 | $33.59 |
Enterprise Value | $15.41B | — |
Dividend Yield | 2.57% | — |
Trailing returns across standard periods
Latest headlines on both assets
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →